Skip to main content

09-29-2021 | EASD 2021 | Conference coverage | Video

The TriMaster study of individualized medicine in type 2 diabetes

Andrew Hattersley outlines the findings from TriMaster, a randomized crossover trial demonstrating the potential of an individualized treatment approach for people with type 2 diabetes who require treatment intensification after first-line metformin (7:39).

00:00 Introduction and aims
01:55 Study population
03:07 Key results
05:56 Clinical implications

Read transcript

Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video